|
HOUSTON, TX--Emerging Healthcare Solutions, Inc. (Pink Sheets: EHSI) announced that the Company has just executed an option with Stand-By Systems, owner of the FDA approved SBS 1615 catalytic oxygen generator and other FDA approved breakthrough emergency portable oxygen systems and devices.
The SBS 1615 catalytic oxygen generator provides medical grade USP oxygen at the push of a button from self-contained inert dry compounds. Stand-By Systems intends to make this portable personal life-saving device (smaller than the size of a soft drink can) become as common in everyday life as first-aid kits, household fire extinguishers and smoke detectors.
According to the American Heart Association, 87.5 million Americans are at risk of heart attack or stroke with the critical need for oxygen even before 911/EMS can respond. Stand-By System’s research leads the company to believe that the critical-need domestic market could translate into $17 billion sales potential at gross margins exceeding 65%
The option agreement allows EHSI management to perform due diligence prior to finalizing a definitive agreement.
“This gives Emerging Healthcare Solutions a great opportunity to be a part of something tremendous,” stated Cindy Morrissey, President of EHSI. “The potential market for these new FDA approved products is immense.”
Emerging Healthcare Solutions focuses on the development of profitable emerging medical technology, a sector that also includes Alcon Inc. (NYSE: ACL), Baxter International (NYSE: BAX), Covidien (NYSE: COV) and Stryker Corporation (NYSE: SYK).
About Emerging Healthcare Solutions, Inc.
Emerging Healthcare Solutions, Inc. is a medical technology company that works to bring new and innovative medical technologies to the market. The Company’s model is to engage a technology prior to its inflection point in order to maximize the profits available to EHSI as that new technology is adopted. Our common stock is traded under the symbol EHSI.
For more information, visit http://www.emerginghealthcaresolutionsinc.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Contact:
Emerging Healthcare Solutions, Inc.
Cindy Morrissey, 713-821-1486
BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section
Add this page to your favorite Social Bookmarking websites
|